Cerevance Media Center

Current News

April 22, 2024

Cerevance Publishes CVN293 in ACS Medicinal Chemistry Letters

Cerevance announces that the peer-reviewed journal, ACS Medicinal Chemistry Letters, has published the manuscript titled “Discovery of CVN293, a Brain Permeable KCNK13 (THIK-1) Inhibitor Suitable for Clinical Assessment”.

READ FULL

February 15, 2024

Cerevance Announces Publication of CVN766 in Bioorganic & Medicinal Chemistry Letters

Cerevance Announces Publication of CVN766 in Bioorganic & Medicinal Chemistry Letters describing the discovery and initial development of CVN766 in the peer-reviewed journal, Bioorganic & Medicinal Chemistry Letters. In the publication titled, “Discovery and first-time disclosure of CVN766, an exquisitely selective orexin 1 receptor antagonist”

READ FULL

November 13, 2023

Cerevance Doses First Patient in ASCEND Phase 2 Clinical Study of CVN424, a First-in-Class, Non-Dopaminergic Therapy for the Treatment of Parkinson’s Disease

Cerevance Doses First Patient in ASCEND Phase 2 Clinical Study of CVN424, a First-in-Class, Non-Dopaminergic Therapy for the Treatment of Parkinson’s Disease

READ FULL

September 19, 2023

Cerevance Doses First Subject in Phase 1 Clinical Study of CVN293, a Selective Inhibitor of KCNK13 Designed to Selectively Modulate Neuroinflammation, for the Treatment of ALS and Alzheimer’s Disease

Cerevance today announced that the first subject has been dosed in the Phase 1 clinical study evaluating the safety, tolerability, and pharmacokinetics of CVN293.

READ FULL

News Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

October 18, 2023

Cerevance to Participate at the Leerink Biopharma Private Company Connect

Date:
Wednesday, October 25, 2023
Time:
Check for open times
Location:
Virtual
Media:
Scheduled Meetings
Read full

October 10, 2023

Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum. Company management will host one-on-one meetings during the conference.

Date:
Tuesday, October 17, 2023
Time:
Check for open times
Location:
Virtual
Media:
Scheduled Meetings
Read full

October 4, 2023

Cerevance to Participate at the 2023 Life Sciences Private Company Showcase

Date:
Thursday, October 12, 2023
Time:
10:05 – 10:25am ET
Location:
New York, NY
Media:
Presentation
Read full

Events Archive

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No items found.

August 14, 2023

A Covalent Binding Mode of a Pyrazole-Based CD38 Inhibitor

Doyle, K., Roberts, M., Harvey, J, Hewer, R., Zebisch, M., Rangel, V., Gu, M., Wu, Y., Yang, L., Carlton, M., Dawson, L. & Bürli, R.

Viewview

October 15, 2018

Species and Cell-Type Properties of Classically Defined Human and Rodent Neurons and Glia

Xu, X., Stoyanova, E.I., Lemiesz, A.E., Xing, J., Mash, D.C., Heintz, N.

Viewview